[SeekAndFind]

Ping for your interest...

Preprint available here:

https://researchgate.net/publication/356962821_Ivermectin_prophylaxis_used_for_COVID-19_reduces_COVID-19_infection_and_mortality_rates_A_220517-subject_populational-level_retrospective_citywide

Results robust to all reasonable confounders in propensity-score matched analysis thanks to a rich data set.

The results can be considered quasi-randomised.

The Brazilian city of Itajai has offered Ivermectin as prophylaxis (0.2mg/day/kg for 2 days every 2 weeks) to its 220,000 inhabitants and meticulously tracked the results.

60% (with higher risk) took IVM over 7 months.

The Covid hospitalization and mortality rates were HALVED.

[Jane Long]

Risk of dying from COVID-19 among ivermectin users was 45% lower than non-users (RR, 0.55; 95%CI, 0.40 – 0.77; p = 0.0004).

Conclusion:
Prophylactic use of ivermectin showed significantly reduced COVID-19 infection rate, mortality rate and chance of dying from COVID-19 on a calculated population-level analysis, which controlled for all relevant confounding variables.

---

Versus the hazardous, adverse effects of the $hots.

I’ll go with the Ivm and natural immunity.